Deutsche Bank
MBX

Deutsche Bank’s MBX Biosciences MBX Stock Holding History

Deutsche Bank’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
31,693
+8,743
+38% +$305K ﹤0.01% 1983
2026
Q1 		$685K Buy
22,950
+2,923
+15% +$99.4K ﹤0.01% 2409
2025
Q4 		$632K Buy
20,027
+9,104
+83% +$221K ﹤0.01% 2448
2025
Q3 		$191K Buy
10,923
+2,161
+25% +$28.9K ﹤0.01% 3084
2025
Q2 		$100K Hold
8,762
– – ﹤0.01% 3257
2025
Q1 		$64.7K Buy
8,762
+4,424
+102% +$46.8K ﹤0.01% 3319
2024
Q4 		$79.9K Buy
+4,338
New +$92.5K ﹤0.01% 3347

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Deutsche Bank's MBX Position: Q2 2026 in Review

Deutsche Bank increased its MBX Biosciences (MBX) stake by 38% in Q2 2026, buying an estimated $305K and bringing the position to 31,693 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Deutsche Bank first reported a position in MBX in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Deutsche Bank held 31,693 shares of MBX Biosciences worth $1.75M as of Q2 2026.
  • Deutsche Bank bought 8,743 MBX Biosciences shares in Q2 2026, an estimated $305K.
  • MBX Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1983 holding.
  • Deutsche Bank first reported a position in MBX Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.